# Mark Woodward

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-woodward/

## Facts

| Field | Value |
| --- | --- |
| Citations | 156,400 |
| Field | Diabetes, Cardiovascular Risks, and Lipoproteins |
| h-index | 179 |
| i10-index | 916 |
| Last Known Institution | University of Technology Sydney |
| OpenAlex ID | https://openalex.org/A5037890696 |
| ORCID iD | https://orcid.org/0000-0001-9800-5296 |
| Works | 1,758 |

## Researcher papers

Showing 12 of 44.

- [Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/intensive-blood-glucose-control-and-vascular-outcomes-in-patients-with-type-2/)
- [Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants](https://scholariq.org/papers/worldwide-trends-in-hypertension-prevalence-and-progress-in-treatment-and/)
- [Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents](https://scholariq.org/papers/body-mass-index-and-all-cause-mortality-individual-participant-data-meta/)
- [Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage](https://scholariq.org/papers/rapid-blood-pressure-lowering-in-patients-with-acute-intracerebral-hemorrhage/)
- [Severe Hypoglycemia and Risks of Vascular Events and Death](https://scholariq.org/papers/severe-hypoglycemia-and-risks-of-vascular-events-and-death/)
- [Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis](https://scholariq.org/papers/associations-of-kidney-disease-measures-with-mortality-and-end-stage-renal/)
- [Intensive glucose control and macrovascular outcomes in type 2 diabetes](https://scholariq.org/papers/intensive-glucose-control-and-macrovascular-outcomes-in-type-2-diabetes/)
- [World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions](https://scholariq.org/papers/world-health-organization-cardiovascular-disease-risk-charts-revised-models-to/)
- [Association of Cardiometabolic Multimorbidity With Mortality](https://scholariq.org/papers/association-of-cardiometabolic-multimorbidity-with-mortality/)
- [Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts](https://scholariq.org/papers/lower-estimated-glomerular-filtration-rate-and-higher-albuminuria-are-associated/)
- [Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease](https://scholariq.org/papers/trial-of-solanezumab-for-mild-dementia-due-to-alzheimer-s-disease/)
- [Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis](https://scholariq.org/papers/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of/)

## Researcher topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [University of Technology Sydney](https://scholariq.org/institutions/university-of-technology-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.